Trevi Therapeutics
TRVI
#4548
Rank
C$3.57 B
Marketcap
C$25.06
Share price
0.67%
Change (1 day)
148.35%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2026 (TTM): -C$65.37 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$60.9 Million, an increase over its 2024 earnings that were of -C$66.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$65.37 Million7.33%
2025 -C$60.9 Million-8.34%
2024 -C$66.44 Million67%
2023 -C$39.79 Million2.43%
2022 -C$38.84 Million-14.45%
2021 -C$45.41 Million1.36%
2020 -C$44.8 Million23.64%
2019 -C$36.23 Million27.54%
2018 -C$28.41 Million